Company: CERO
Filing Date: 2025-11-17
Form Type: PRE 14A
Source: 0001213900-25-111175
Chunk: 9

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-11-17
Form: PRE 14A
Chunk 9
---
 of a Broker or Bank If, on the Record Date, your shares were held, not in your name, but rather in an account at a brokerage firm, bank, dealer or other similar organization, then you are the beneficial owner of shares held in “street name.” The organization holding your account is considered to be the stockholder of record for purposes of voting at the Special Meeting. As a beneficial owner, you have the right to direct your broker or other agent regarding how to vote the shares in your account. You are also invited to attend the Special Meeting via the internet at https://www.cstproxy.com/cero/sm2025. However, because you are not the stockholder of record, you may not vote your shares live online at the Special Meeting unless you request and obtain a valid proxy from your broker or other agent. How can I attend the Special Meeting? If you are a stockholder of record or a beneficial owner as of the Record Date, you are invited to attend the Special Meeting live via the internet at https://www.cstproxy.com/cero/sm2025. You must have your 16 -digitcontrol number listed on the proxy card or in the instructions that accompanied your proxy materials to enter the meeting. The 2 webcast starts atPacific Time. You may vote and submit questions while attending the meeting on the internet. Instructions on how to attend and participate in the Special Meeting via the internet, including how to demonstrate proof of stock ownership, will be posted at https://www.cstproxy.com/cero/sm2025. What if I return the proxy card to the Company but do not make specific choices? If you return a signed, dated proxy card to the Company without making any voting selections, the named proxies will vote your shares: • “FOR” Proposal No. 1:The approval of an amendment to our Certificate of Incorporation to combine outstanding shares of our Common Stock into a lesser number of outstanding shares, by a ratio of not less than one -for-40and not more than one -for-150, with the exact ratio to be set within this range by our Board in its sole discretion. • “FOR” Proposal No. 2:The approval, subject to certain conditions, of the issuance of shares of Common Stock in accordance with Nasdaq Listing Rule 5635, upon conversion of the Series E Preferred Stock issued in the October 2025 Private Placement. • “FOR” Proposal No. 3:The approval of the 2024 Plan, as amended to increase the number of